Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07298746Not yet recruiting
Open-label trial of lidocaine and mepivacaine in cataract (4 arms), sponsored by Sohag University. Primary endpoint: Macular superficial capillary plexus (SCP) and deep capillary plexus (DCP). Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07298746.